Morton Capital Management »

Telomir Pharmaceuticals shares owned by Morton Capital Management

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Morton Capital Management from 13F filings

Historical chart of Morton Capital Management investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Morton Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Morton Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $17k 13k 1.33

More positions owned by Morton Capital Management

Vaneck Merk Gold Etf Gold Shs (OUNZ)
Wisdomtree Tr Floatng Rat Trea (USFR)
Dimensional Etf Trust World Ex Us Core (DFAX)
Tcw Etf Trust Flexible Income (FLXR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vaneck Etf Trust Natural Resourc (HAP)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Rus 1000 Val Etf (IWD)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Invesco Exchange Traded Fd T Intl Divi Achi (PID)

View all positions for Morton Capital Management

Top funds holding Telomir Pharmaceuticals

Vanguard Group
BlackRock
Geode Capital Management
Millennium Management
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Northern Trust
XTX Topco
Pensionmark Financial Group
Advisor Group Holdings
Resources Investment Advisors
Virtu Financial
UBS Group
Vestmark Advisory Solutions

View all funds holding Telomir Pharmaceuticals